Advertisement

Cytek Biosciences, Inc. CTKB

Set alert

Price alert · CTKB

All alert types
6.13 USD -0.17 -2.70%

At close · Oct 30

6.13 0.00 0.00%

After hours · Oct 30, 4:33 PM ET

Bid
6.12 × 2
Ask
6.13 × 2
6.05 Day range 6.28
3.36 52-week range 6.30
YTD
+21.39%
1 year
+60.47%
Open
6.26
Prev close
6.30
Mkt cap
796.80M
Vol
1.87M
Avg vol
1.19M
EPS
-0.62
P/E
0.00
Div yield
0.00%
More statistics
Low
6.05
High
6.28
Forward P/E
107.67
Beta
1.32
Short ratio
4.50
Inst. own
59.02%
Dividend
0.00
Ex-div date
Earnings
Aug 6, 2024
50-d avg
6.03
200-d avg
5.92
1y target
8.40

2Y chart

Chart tools
Interval

Events in this range
  • Nov 5, 2024Earnings: 0.01; estimate -0.02; surprise 150%
  • Nov 11, 2024Rating: Piper Sandler · Overweight → Overweight
Signals (105)
NameDateAgo
RSI: OverboughtOct 29, 20262 days ago
MACD: Buy SignalOct 26, 20265 days ago
MACD: Sell SignalOct 7, 20263 weeks ago
RSI: OverboughtOct 2, 20264 weeks ago
RSI: OverboughtSep 22, 20261 month ago
MACD: Buy SignalSep 15, 20261 month ago
SMA: BullishSep 11, 20261 month ago
SMA: BullishSep 11, 20261 month ago
SMA: BearishSep 10, 20261 month ago
SMA: BearishSep 10, 20261 month ago
MACD: Sell SignalSep 1, 20262 months ago
MACD: Buy SignalAug 31, 20262 months ago
MACD: Sell SignalAug 25, 20262 months ago
SMA: BearishAug 24, 20262 months ago
MACD: Buy SignalAug 11, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BullishAug 10, 20262 months ago
SMA: BearishAug 4, 20262 months ago
SMA: BullishAug 3, 20262 months ago
SMA: BearishJul 31, 20263 months ago
SMA: BearishJul 22, 20263 months ago
MACD: Sell SignalJul 21, 20263 months ago
SMA: BullishJul 14, 20263 months ago
SMA: BearishJul 13, 20263 months ago
SMA: BullishJul 9, 20263 months ago
SMA: BearishJul 8, 20263 months ago
SMA: BullishJul 1, 20264 months ago
SMA: BullishJun 24, 20264 months ago
MACD: Buy SignalJun 23, 20264 months ago
MACD: Sell SignalJun 18, 20264 months ago
MACD: Buy SignalMay 27, 20265 months ago
RSI: OversoldMay 13, 20265 months ago
SMA: BearishMay 11, 20265 months ago
SMA: BearishMay 11, 20265 months ago
MACD: Sell SignalMay 11, 20265 months ago
MACD: Buy SignalMay 4, 20266 months ago
SMA: BullishApr 27, 20266 months ago
SMA: BullishApr 27, 20266 months ago
SMA: BearishApr 23, 20266 months ago
SMA: BearishApr 23, 20266 months ago
MACD: Sell SignalApr 23, 20266 months ago
SMA: BullishApr 2, 20267 months ago
SMA: BearishMar 24, 20267 months ago
SMA: BullishMar 23, 20267 months ago
SMA: BullishMar 17, 20267 months ago
MACD: Buy SignalMar 17, 20267 months ago
MACD: Sell SignalMar 12, 20267 months ago
SMA: BearishMar 11, 20267 months ago
MACD: Buy SignalFeb 24, 20268 months ago
RSI: OversoldFeb 17, 20268 months ago
RSI: OversoldFeb 12, 20268 months ago
RSI: OversoldFeb 10, 20268 months ago
SMA: BearishJan 26, 20269 months ago
MACD: Sell SignalJan 21, 20269 months ago
MACD: Buy SignalJan 5, 20269 months ago
MACD: Sell SignalDec 2, 202511 months ago
RSI: OverboughtNov 21, 202511 months ago
RSI: OverboughtNov 18, 202511 months ago
RSI: OverboughtNov 14, 202511 months ago
RSI: OverboughtNov 10, 202511 months ago
MACD: Buy SignalNov 6, 202511 months ago
SMA: BullishNov 5, 202512 months ago
SMA: BullishNov 5, 202512 months ago
SMA: BearishNov 4, 202512 months ago
SMA: BearishNov 4, 202512 months ago
SMA: BullishNov 3, 202512 months ago
SMA: BullishNov 3, 202512 months ago
SMA: BearishOct 30, 20251 year ago
SMA: BearishOct 30, 20251 year ago
MACD: Sell SignalOct 30, 20251 year ago
SMA: BullishOct 21, 20251 year ago
SMA: BullishOct 13, 20251 year ago
SMA: BearishOct 10, 20251 year ago
SMA: BullishOct 8, 20251 year ago
SMA: BearishOct 7, 20251 year ago
SMA: BullishOct 3, 20251 year ago
MACD: Buy SignalOct 3, 20251 year ago
SMA: BearishSep 23, 20251 year ago
SMA: BullishSep 22, 20251 year ago
SMA: BearishSep 19, 20251 year ago
SMA: BullishSep 11, 20251 year ago
SMA: BearishSep 10, 20251 year ago
MACD: Sell SignalAug 21, 20251 year ago
MACD: Buy SignalJul 25, 20251 year ago
SMA: BullishJul 22, 20251 year ago
SMA: BearishJul 18, 20251 year ago
MACD: Sell SignalJul 14, 20251 year ago
SMA: BullishJun 25, 20251 year ago
SMA: BearishJun 13, 20251 year ago
SMA: BullishJun 6, 20251 year ago
MACD: Buy SignalMay 30, 20251 year ago
RSI: OversoldMay 13, 20251 year ago
MACD: Sell SignalMay 9, 20251 year ago
RSI: OversoldMay 9, 20251 year ago
MACD: Buy SignalApr 11, 20251 year ago
MACD: Sell SignalApr 7, 20251 year ago
RSI: OversoldApr 3, 20251 year ago
MACD: Buy SignalMar 17, 20251 year ago
RSI: OversoldMar 11, 20251 year ago
RSI: OversoldFeb 28, 20251 year ago
MACD: Sell SignalFeb 27, 20251 year ago
MACD: Buy SignalFeb 18, 20251 year ago
SMA: BearishJan 15, 20251 year ago
MACD: Sell SignalJan 15, 20251 year ago
MACD: Buy SignalJan 3, 20251 year ago

Key statistics

Market cap
832.12M
Enterprise value
550.82M
Trailing P/E
0.00
Forward P/E
107.67
PEG ratio
0.00
Price / sales
4.14
Price / book
2.18
EPS (TTM)
-0.08
Beta
1.32
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-5.05%
Revenue (TTM)
201.21M
Revenue growth
7.30%
Free cash flow
40.66M
Total cash
277.78M
Total debt
14.52M
Return on equity
-2.54%
Shares outstanding
128.81M
Short % of float
3.95%
50-day average
6.03
200-day average
5.92

Analyst view

Consensus: buy

Buy
Price target (mean) 8.40 +37.0% upside
Target (low)
7.00
Target (mean)
8.40
Target (high)
9.00
Ratings (0m) 6 4 buy · 2 hold · 0 sell
  • Strong buy2
  • Buy2
  • Hold2
  • Sell0
  • Strong sell0

Next earnings

Aug 6, 2024

Expected Aug 6, 2024. Consensus EPS estimate 0.11333.

Earnings history

Financials — quick view

All financials
CTKB Revenue — quarterly 48.14M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CTKB Net income — quarterly -12.16M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CTKB EPS — quarterly -0.09
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CTKB recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2024Sep 1, 2024-0.020.01+0.03+150.00%
Aug 6, 2024Jun 1, 2024-0.03———
Aug 6, 2024Jun 1, 2024-0.03-0.08-0.05-166.67%
May 8, 2024Mar 1, 2024-0.05-0.050.000.00%
May 8, 2024Mar 1, 2024-0.05———
Nov 7, 2023Sep 1, 20230.02———

Upgrades / downgrades

CTKB analyst upgrades and downgrades
DateFirmActionFromTo
Nov 11, 2024Piper SandlermainOverweightOverweight
Aug 13, 2024Piper SandlermainOverweightOverweight
May 13, 2024Piper SandlermainOverweightOverweight
Mar 6, 2024Piper SandlermainOverweightOverweight
Feb 29, 2024Goldman SachsmainBuyBuy
Dec 14, 2023Stephens & Co.init—Overweight

About Cytek Biosciences, Inc.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States
Website
cytekbio.com

News

Your note

Sign in to keep a note on CTKB — it syncs with the Stock Master app.

Insider holders

CTKB insider holders
InsiderRelationLatest transactionDateShares held
BARNETT VALERIEOfficerConversion of Exercise of derivative securityNov 17, 202462,850
BUSQUE PHILIPPEOfficerConversion of Exercise of derivative securityNov 17, 202412,871
GARLAND JONATHAN TODDOfficerConversion of Exercise of derivative securityAug 17, 20238,763
HOLDER MICHAELDirectorConversion of Exercise of derivative securityNov 17, 20243,635
JEANMONOD PATRIKChief Financial OfficerConversion of Exercise of derivative securityMar 10, 202497,465
JIANG WENBINChief Executive OfficerConversion of Exercise of derivative securityNov 17, 20245,187,640

Institution ownership

CTKB institution ownership
Holder% heldSharesValueReported
Blackrock Inc.14.36%18,492,291119.46MSep 29, 2024
Vanguard Group Inc9.14%11,778,05476.09MSep 29, 2024
Brown Capital Management, LLC7.37%9,493,47461.33MSep 29, 2024
HHLR Advisors, LTD5.17%6,657,03043.00MSep 29, 2024
State Street Corporation3.24%4,167,50126.92MSep 29, 2024
Geode Capital Management, LLC2.07%2,668,00417.24MSep 29, 2024

Fund ownership

CTKB fund ownership
Holder% heldSharesValueReported
iShares Core S&P Smallcap ETF5.29%6,819,16744.05MOct 30, 2024
Vanguard Total Stock Market Index Fund2.70%3,474,08422.44MSep 29, 2024
Brown Capital Management Small Company Fund2.69%3,464,59022.38MSep 29, 2024
iShares Russell 2000 ETF2.42%3,121,61920.17MOct 30, 2024
Vanguard Small-Cap Index Fund2.05%2,637,31017.04MSep 29, 2024
Vanguard Extended Market Index Fund1.20%1,542,1819.96MSep 29, 2024
Advertisement